
Please try another search
InnoCan Pharma Corporation, a pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally. The company operates in two segments: Online Sales and Other Operations. It engages in the research and development of CBD loaded exosomes, as well as operates LPT CBD-loaded liposome platform that facilitates exact dosing and the prolonged and controlled release of CBD into the blood stream for epilepsy and pain management. The company is involved in the development and sale of CBD-integrated pharmaceuticals and topical products. In addition, it develops and markets a portfolio of self-care products for healthier lifestyle. The company was incorporated in 2018 and is headquartered in Calgary, Canada.
Name | Age | Since | Title |
---|---|---|---|
Andrew Goldman | - | 2021 | Director |
Iris Bincovich | 56 | 2018 | CEO & Interim Chair |
Peter David Bloch | 66 | 2020 | Independent Director |
Eyal Flom | 59 | 2019 | Company Secretary, General Counsel & Director |
Roni Kamhi | 50 | 2021 | COO & Director |
Joshua A. Lintern | 38 | 2019 | Independent Director |
Antonio M. Benitz | 75 | 2024 | Animal Health R&D Advisor |
Joseph V. Pergolizzi | 55 | 2023 | Member of Scientific Advisory Board |
Yechezkel Barenholz | 83 | - | Scientific Advisor |
Ron Mayron | 62 | 2019 | Advisor |
Ralph C. L. Bossino | 37 | 2019 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review